Jonathan Van-Tam says less effective vaccine may be used if that is what is available

A vaccine that potentially does not work as well as the Pfizer/BioNTech candidate is still likely to be given to people in the UK in the interests of saving lives at speed, government scientific advisers have said.

The UK has invested heavily in the Oxford/AstraZeneca potential vaccine, which is likely to reveal its first efficacy data this month. Pfizer and BioNTech have reported 90% efficacy in preventing people from becoming ill, but the UK will not get more than a small amount of that vaccine before next year. It could end up in the position of having more doses available of a vaccine with less efficacy.

Continue reading…

You May Also Like

Extinction Rebellion blockades Amazon UK hubs on Black Friday

Activists target distribution network to highlight company’s treatment of workers and environmental…

Covid denialist and Bolsonaro ally Olavo de Carvalho died of virus, says daughter

Rightwing radical was a towering figure in Brazil who was adored and…

Former Swedish intelligence officer jailed for life for spying for Russia

Judge says Peyman Kia abused trust placed in him, and also sentences…